We are live on ! Find out more
PHS

Pekin Hardy Strauss Portfolio holdings

AUM $957M
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+4.09%
1 Year Est. Return
+44.61%
3 Year Est. Return
+97.85%
5 Year Est. Return
+135.39%
10 Year Est. Return
+315.22%
AUM
$644M
AUM Growth
+$12.8M
Cap. Flow
-$9.02M
Cap. Flow %
-1.4%
Top 10 Hldgs %
47.92%
Holding
135
New
7
Increased
29
Reduced
56
Closed
8

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$14.7M
2
SEE
Sealed Air
SEE
+$13.5M
3
SKM icon
SK Telecom
SKM
+$8.62M
4
HLF icon
Herbalife
HLF
+$7.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.77M

Sector Composition

Rank Sector Weight
1 Financials 21.82%
2 Healthcare 12.96%
3 Industrials 11.69%
4 Consumer Staples 10.89%
5 Energy 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
26
Bank of New York Mellon
BNY
$105B
$7.48M 1.16%
214,009
-4,100
-2% -$133K
GE icon
27
GE Aerospace
GE
$370B
$5.49M 0.85%
40,873
-1,381
-3% -$174K
MRK icon
28
Merck
MRK
$323B
$5.23M 0.81%
109,464
-3,397
-3% -$155K
SYKE
29
DELISTED
SYKES Enterprises Inc
SYKE
$5.12M 0.79%
234,625
-5,350
-2% -$107K
JNJ icon
30
Johnson & Johnson
JNJ
$645B
$4.8M 0.74%
52,373
-1,801
-3% -$166K
PEP icon
31
PepsiCo
PEP
$198B
$3.97M 0.62%
47,873
+1,915
+4% +$159K
RNF
32
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
$3.82M 0.59%
+217,090
New +$4.7M
CNI icon
33
Canadian National Railway
CNI
$78.3B
$3.8M 0.59%
66,577
-1,805
-3% -$99.3K
GDX icon
34
VanEck Gold Miners ETF
GDX
$22.3B
$3.5M 0.54%
165,740
-14,325
-8% -$331K
IDXG
35
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$3.09M 0.48%
6,428
AAPL icon
36
Apple
AAPL
$5.01T
$2.93M 0.45%
146,188
-10,220
-7% -$193K
VWTR
37
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$2.91M 0.45%
126,025
-98,866
-44% -$2.32M
VWO icon
38
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$2.58M 0.4%
62,770
-6,875
-10% -$283K
PM icon
39
Philip Morris
PM
$313B
$2.56M 0.4%
29,371
EMR icon
40
Emerson Electric
EMR
$83B
$2.4M 0.37%
34,188
-400
-1% -$26.7K
ZBRA icon
41
Zebra Technologies
ZBRA
$13.5B
$2.08M 0.32%
38,400
CVX icon
42
Chevron
CVX
$384B
$2.02M 0.31%
16,200
GLD icon
43
SPDR Gold Trust
GLD
$130B
$1.98M 0.31%
17,065
-1,000
-6% -$123K
PG icon
44
Procter & Gamble
PG
$339B
$1.83M 0.28%
22,491
-403
-2% -$32.8K
IBM icon
45
IBM
IBM
$214B
$1.79M 0.28%
9,962
+398
+4% +$68.6K
PSLV icon
46
Sprott Physical Silver Trust
PSLV
$11.7B
$1.72M 0.27%
227,085
-91,250
-29% -$754K
NLY icon
47
Annaly Capital Management
NLY
$17.4B
$1.72M 0.27%
43,054
-47,195
-52% -$2.05M
BRK.B icon
48
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.7M 0.26%
14,343
BMY icon
49
Bristol-Myers Squibb
BMY
$130B
$1.59M 0.25%
29,918
-9,000
-23% -$458K
IVV icon
50
iShares Core S&P 500 ETF
IVV
$865B
$1.58M 0.25%
8,530
-1,250
-13% -$223K

Similar funds

Pekin Hardy Strauss's Q4 2013 Portfolio in Review

As of Q4 2013, Pekin Hardy Strauss held 135 positions worth $644M, up 2% from $631M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Pekin Hardy Strauss's Q4 2013 filing shows 7 new, 29 increased, 56 reduced and 8 closed positions. Its largest new stake was FTD Companies, Inc. Common Stock: 619,610 shares worth $20.2M. The largest sale was Microsoft, an estimated $14.7M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Pekin Hardy Strauss's largest Q4 2013 buy was FTD Companies, Inc. Common Stock: 619,610 shares worth $20.2M.
  • Pekin Hardy Strauss added most to Teva Pharmaceuticals in Q4 2013, an estimated $6.63M increase.
  • Pekin Hardy Strauss's biggest Q4 2013 reduction was Microsoft, cutting an estimated $14.7M.
  • Pekin Hardy Strauss fully exited Sealed Air in Q4 2013, selling an estimated $13.5M.
  • Pekin Hardy Strauss's ten largest holdings make up 48% of its $644M portfolio in Q4 2013.
  • Pekin Hardy Strauss opened 7 new positions and closed 8 in Q4 2013.
  • Pekin Hardy Strauss's portfolio value rose 2% quarter-over-quarter to $644M.

Based on Pekin Hardy Strauss's 13F filing for Q4 2013, filed 11 Feb 2014.